Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double-blind, Phase 3b Study

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

(2013) Keiichiro Imanaka et al.   CURRENT MEDICAL RESEARCH AND OPINION

The international CHANGE PAIN physician survey: does specialism influence the perception of pain and its treatment?

(2012) G. Varrassi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study

(2012) Ilona Steigerwald et al.   CURRENT MEDICAL RESEARCH AND OPINION

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study

(2012) Ilona Steigerwald et al.   Journal of Pain Research

Combination Therapy for Neuropathic Pain

(2011) Yakov Vorobeychik et al.   CNS DRUGS

Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact

(2011) Kim J. Reid et al.   CURRENT MEDICAL RESEARCH AND OPINION

Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain

(2010) Bernd Lange et al.   ADVANCES IN THERAPY

Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee

(2010) Marc Afilalo et al.   CLINICAL DRUG INVESTIGATION

Pregabalin for Peripheral Neuropathic Pain

(2010) Ian Gilron et al.   CLINICAL JOURNAL OF PAIN

Pharmacological treatment of chronic pain – the need for CHANGE

(2010) G. Varrassi et al.   CURRENT MEDICAL RESEARCH AND OPINION

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

(2010) Sherwyn Schwartz et al.   CURRENT MEDICAL RESEARCH AND OPINION

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision

(2010) N. Attal et al.   EUROPEAN JOURNAL OF NEUROLOGY

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

(2010) Robert Buynak et al.   EXPERT OPINION ON PHARMACOTHERAPY

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

(2010) Robert H. Dworkin et al.   MAYO CLINIC PROCEEDINGS

Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain

(2010) James E. Wild et al.   Pain Practice

Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage

(2009) Michael Costigan et al.   Annual Review of Neuroscience

Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients

(2008) Magdi Hanna et al.   EUROPEAN JOURNAL OF PAIN

Prevalence of Chronic Pain in a Representative Sample in the United States

(2008) Jochen Hardt et al.   PAIN MEDICINE